-
Mashup Score: 25Transcatheter Repair versus Mitral-Valve Surgery for Secondary Mitral Regurgitation | NEJM - 9 day(s) ago
Current treatment recommendations for patients with heart failure and secondary mitral regurgitation include transcatheter edge-to-edge repair and mitral-valve surgery. Data from randomized trials …
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 19
Title: Approach to long diffused coronary artery disease Introduction : Recent innovations in coronary artery stenting “ The Ultimaster Nagomi “ Speaker : Dr. Rasha Albawardi Ultimaster Nagomi stent system Studies update Speaker : Dr. Rasha Albawardi Cases presentation: -Case#1 : Saudi German Hospital Dammam Speaker : Dr. Hamed Alghamdi -Case#2 King Saud Medical City Riyadh Speaker : Dr. Khaled AlHarbi -Case#3 : Madina Cardiac Center Madina Speaker : Dr. Maher tolba -Case#4 : King Fahad Armed Forces Hospital Jeddah Speaker : Dr. Habib waqar. – Open Discussion
Source: us06web.zoom.usCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 25Transcatheter Repair versus Mitral-Valve Surgery for Secondary Mitral Regurgitation | NEJM - 14 day(s) ago
Current treatment recommendations for patients with heart failure and secondary mitral regurgitation include transcatheter edge-to-edge repair and mitral-valve surgery. Data from randomized trials …
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
@escardio #ESCCongress @PCRonline @nejm https://t.co/nQzEmBsKCw MATTERHORN trial shows that in patients with heart failure and secondary mitral regurgitation, transcatheter edge-to-edge repair is non-inferior to surgery regarding clinical efficacy, and has a better safety… https://t.co/5942N6mROs https://t.co/YHEM0FlUDM
-
-
Mashup Score: 4
A 64-year-old man underwent successful salvage angioplasty on an occluded right coronary artery after a failed thrombolysis for an acute inferior myocardial infarction. A second successful stenting procedure was performed 1 week later with Taxus drug-eluting stents (Boston Scientific) on further significant disease in the left mainstem and proximal left anterior descending artery. Both procedures were performed via the right radial approach with a 6F Cook sheath (William Cook Europe). The patient presented
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
@Hragy @nolanjimradial @mmamas1973 @SVRaoMD I wonder how many go unnoticed as we don’t routinely test for thrill or US Compression may help if acute..seems most are referred for surgical ligation Here are several case reports ⤵️ https://t.co/g73nInFkuZ https://t.co/CNrXwikDmG https://t.co/ShZkBA3rHg
-
-
Mashup Score: 3National Heart Forum - 23 day(s) ago
On behalf of the National Heart Center, I am thrilled to invite you to the 3 rd National Heart Forum in KSA. This event is designed to bring together colleagues, and experts to share knowledge and foster networking, friendship, and collaboration. We have assembled a distinguished faculty of leading cardiologists to guide the forum and develop its scientific program. I would like to take this opportunity to express my sincere gratitude to all the distinguished speakers, both local and international, who
Source: heartforum-sa.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 15Renal denervation – radiofrequency vs. ultrasound: insights ... : Journal of Hypertension - 25 day(s) ago
(rRDN) and ultrasound RDN (uRDN), when compared with sham in patients with hypertension. Methods: PubMed, EMBASE, and clinicaltrials.gov databases were searched for randomized sham-controlled trials (RCTs) of rRDN or uRDN or for trials of rRDN vs. uRDN. Primary efficacy outcome was 24-h ambulatory SBP. A mixed treatment comparison meta-analysis was performed comparing the efficacy and safety against sham and against each other. Results: Among 13 RCTs that enrolled 2285 hypertensive patients, rRDN reduced 24-h ambulatory SBP [(MD = 2.34 mmHg; 95% confidence interval (95% CI): 0.72–3.95], office SBP (MD = 5.04 mmHg; 95% CI: 2.68–7.40)], and office DBP (MD = 2.95 mmHg; 95% CI: 1.68–4.22) when compared with sham. Similarly, uRDN reduced 24-h ambulatory SBP (MD = 4.74 mmHg; 95% CI: 2.80–6.67), day-time ambulatory SBP (MD = 5.40 mmHg; 95% CI: 3.68–7.13), night-time ambulatory SBP (MD = 3.84 mmHg; 95% CI: 0.02–7.67), and office SBP (3.98 mmHg; 95% CI: 0.78–7.19) when compared with sham. There
Source: journals.lww.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 17TCT 2024: Transcatheter aortic valve replacement in patients with systolic heart failure and moderate aortic stenosis (TAVR UNLOAD) - 1 month(s) ago
Mirvat Alasnag interviews Nicolas M. Van Mieghem about the results of the TAVR UNLOAD trial he presented at the TCT Conference 2024.
Source: www.pcronline.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 16TCT 2024: Transcatheter aortic valve replacement in patients with systolic heart failure and moderate aortic stenosis (TAVR UNLOAD) - 1 month(s) ago
Mirvat Alasnag interviews Nicolas M. Van Mieghem about the results of the TAVR UNLOAD trial he presented at the TCT Conference 2024.
Source: www.pcronline.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3National Heart Forum - 1 month(s) ago
On behalf of the National Heart Center, I am thrilled to invite you to the 3 rd National Heart Forum in KSA. This event is designed to bring together colleagues, and experts to share knowledge and foster networking, friendship, and collaboration. We have assembled a distinguished faculty of leading cardiologists to guide the forum and develop its scientific program. I would like to take this opportunity to express my sincere gratitude to all the distinguished speakers, both local and international, who
Source: heartforum-sa.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 27
Background: The Placebo-controlled Trial of Percutaneous Coronary Intervention for the Relief of Stable Angina (ORBITA-2) provided evidence for the role of percutaneous coronary intervention (PCI) for angina relief in stable coronary artery disease (CAD). Fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) are often used to guide PCI, however their ability to predict placebo-controlled angina improvement is unknown. Methods: Participants with angina, ischemia, and stable CAD were enrolled and antianginal medications were stopped. Participants reported angina episodes daily for 2 weeks using the ORBITA-app. At the research angiogram, FFR and iFR were measured. After sedation and auditory isolation, participants were randomized to PCI or placebo, before entering a 12-week blinded follow-up phase with daily angina reporting. The ability of FFR and iFR, analyzed as continuous variables, to predict the placebo-controlled effect of PCI, was tested using Bayesian proportiona
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
@escardio #ESCCongress @PCRonline @nejm https://t.co/nQzEmBsKCw MATTERHORN trial shows that in patients with heart failure and secondary mitral regurgitation, transcatheter edge-to-edge repair is non-inferior to surgery regarding clinical efficacy, and has a better safety… https://t.co/5942N6mROs https://t.co/YHEM0FlUDM